Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2012
04/03/2012US8147730 Synthesis of small particles
04/03/2012CA2586379C Site-directed modification of fviii
04/03/2012CA2530042C Compositions and methods for reducing lung volume
04/03/2012CA2501690C Amended recombinant cells (arcs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants
04/03/2012CA2493329C Releasable polymeric conjugates based on aliphatic biodegradable linkers
04/03/2012CA2481936C Canola protein isolate compositions
04/03/2012CA2459309C Sustained release of microcrystalline peptide suspensions
04/03/2012CA2454618C Methods for treating or preventing sclerotic disorders using cd2-binding agents
04/03/2012CA2453115C Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
04/03/2012CA2435466C Use of il-18 inhibitors for the treatment and/or prevention of heart disease
04/03/2012CA2432792C Methods for modulating tumor growth and metastasis
04/03/2012CA2398445C A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
04/03/2012CA2379220C Structural protein of adeno-associated virus with modified antigenicity, its production and its use
04/03/2012CA2374675C Modified factor viii
04/03/2012CA2347411C Virus-like particles for the induction of autoantibodies
04/03/2012CA2198461C Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a prrsv
04/01/2012CA2716236A1 Compositions for the treatment of hcv and hbv
03/2012
03/29/2012WO2012040633A1 Compounds that enable alternative mitochondrial electron transfer
03/29/2012WO2012040459A2 Beta-catenin targeting peptides and uses thereof
03/29/2012WO2012040421A1 Formulations for bovine granulocyte colony stimulating factor and variants thereof
03/29/2012WO2012040364A1 Calcitonin products and therapies for treating inflammatory or degenerative diseases
03/29/2012WO2012040323A2 Multimeric il-15 soluble fusion molecules and methods of making and using same
03/29/2012WO2012040295A2 Therapeutic applications of smad7
03/29/2012WO2012040242A1 Substituted proline inhibitors of hepatitis c virus replication
03/29/2012WO2012040167A1 Macrocyclic proline derived hcv serine protease inhibitors
03/29/2012WO2012040164A2 Tlr5 ligands, therapeutic methods, and compositions related thereto
03/29/2012WO2012040101A1 Compositions and methods for inducing migration by dendritic cells and an immune response
03/29/2012WO2012040095A1 Qsox1 as an anti-neoplastic drug target
03/29/2012WO2012040062A1 Mosquitocidal xenorhabdus, lipopeptide and methods
03/29/2012WO2012039578A2 Composition for preventing and treating amyloid diseases, comprising cyclophilin b
03/29/2012WO2012038953A2 Fgf-18 truncated variants having increased receptor specificity and uses thereof
03/29/2012WO2012038950A1 Activatable toxin complexes comprising a cleavable inhibitory peptide
03/29/2012WO2012038918A1 Therapeutic product inhibitor of the cell proliferation and biological applications thereof
03/29/2012WO2012038512A2 Composition comprising sod, lutein and zeaxanthin
03/29/2012WO2012037778A1 Polypeptide tf1 for inhibiting type 2 shiga toxin activity, encoding gene for same and use thereof
03/29/2012WO2012037771A1 Analgesic active peptide vgg, preparation and use thereof
03/29/2012WO2012037687A1 Therapeutic polypeptides and uses thereof
03/29/2012WO2012037616A1 Interferon-nu
03/29/2012WO2012037612A1 Novel immunostimulatory method
03/29/2012WO2012037603A1 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions
03/29/2012WO2012018145A3 Agent for improving quality of life
03/29/2012WO2012006566A3 Microcrystalline y receptor agonists
03/29/2012WO2012004664A3 Analogs of sodium channel peptide toxin
03/29/2012WO2011160082A3 Therapeutic and cosmetic uses and applications of calreticulin
03/29/2012WO2011153485A3 Use of the sparc microenvironment signature in the treatment of cancer
03/29/2012WO2011151826A3 An expeditious synthesis of ubiquitinated peptide conjugates
03/29/2012WO2011151814A3 Caged cell penetrating peptide-polymer conjugates for diagnostic and therapeutic applications
03/29/2012WO2011140267A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
03/29/2012WO2011140266A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases
03/29/2012WO2011140132A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
03/29/2012WO2011139907A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
03/29/2012WO2011139801A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
03/29/2012WO2011133879A3 Combination therapies with mitochondrial-targeted anti-tumor agents
03/29/2012WO2011130729A3 Methods for treating metabolic disorders using fgf
03/29/2012WO2011130686A3 Promoting erythropoietin, erythrocyte, and hematopoietic stem cell production by activating hif in osteoblasts
03/29/2012WO2011100688A8 Improved antagonists of muc1
03/29/2012WO2011084711A3 Hair growth methods using fgfr3 extracellular domains
03/29/2012US20120079614 Cd109 polypeptides and uses thereof for the treatment of skin cells
03/29/2012US20120079613 Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity
03/29/2012US20120078229 In vivo bioreactors and methods of making and using same
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077862 Antisense modulation of ptp1b expression
03/29/2012US20120077861 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
03/29/2012US20120077759 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation
03/29/2012US20120077758 Infertility associated defb-126 deletion polymorphism
03/29/2012US20120077757 Methods for Affecting Homology-Directed DNA Double Stranded Break Repair
03/29/2012US20120077756 Methods, compositions, and kits for the treatment of ophthalmic disorders
03/29/2012US20120077755 Compounds For, and Methods of, Treating Cancer and Inhibiting Invasion and Metastases
03/29/2012US20120077754 Copolymer-1 improvements in compositions of copolymers
03/29/2012US20120077753 Jnk inhibitors for use in treating spinal muscular atrophy
03/29/2012US20120077752 Composition for improving brain function and method for improving brain function
03/29/2012US20120077751 Methods for modulating neuronal responses
03/29/2012US20120077750 Use of a growth-stimulating protein
03/29/2012US20120077749 Biologically Active Peptides
03/29/2012US20120077748 Materials and Methods for Improving Gastrointestinal Function
03/29/2012US20120077747 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent
03/29/2012US20120077746 Glp-1 analogues pharmaceutical compositions
03/29/2012US20120077745 Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
03/29/2012US20120077744 Steroid-sparing methods of treating brain edema
03/29/2012US20120077743 Methods of treating cartilage defects
03/29/2012US20120077742 Expression System Of NELL Peptide
03/29/2012US20120077741 Treatment of Central Nervous System Disorders
03/29/2012US20120077740 Methods for making Apo-2 Ligand using divalent metal ions
03/29/2012US20120077739 Methods for treating obesity employing an sglt2 inhibitor and compositions thereof
03/29/2012US20120077738 Compositions and methods for predicting hcv susceptibility to antiviral agents
03/29/2012US20120077737 Hepatitis c inhibitor compounds
03/29/2012US20120077736 Inhibitor against forming biofilm comprising k-casein macropeptide
03/29/2012US20120077735 Prophylactic agent for renal failure
03/29/2012US20120077734 Methods and assays for treating conditions in which macrophages play a pathogenic role
03/29/2012US20120077733 Antagonists against interaction of pf4 and rantes
03/29/2012US20120077732 Cyclic peptides and uses thereof
03/29/2012US20120077731 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
03/29/2012US20120077730 Method for in Vitro Molecular Evolution of Protein Function
03/29/2012US20120077226 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
03/29/2012US20120076868 Cross-linked bioactive hydrogel matrices
03/29/2012US20120076866 Particulate pharmaceutical composition
03/29/2012US20120076862 Methods of enhancing drug delivery and effectiveness of therapeutic agents
03/29/2012US20120076861 Materials and methods for the treatment of celiac disease
03/29/2012US20120076856 Orodispersible pharmaceutical composition of perindopril
03/29/2012US20120076851 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
1 ... 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 ... 3163